Dr. Dan Broder is the lead scientist for IDEXX’s Legiolert R&D team. Legiolert is a new quantitative culture-based method which simplifies the detection of Legionella pneumophila in water samples. He is currently co-authoring international field trial studies on the performance of Legiolert vs. standard method technologies. Previously, Broder was a senior scientist at a molecular diagnostics company specializing in genetic profile characterization. He earned his PhD in microbiology from the University of Illinois at Urbana-Champaign, where he studied the biochemistry and metabolism associated with proteolytic breakdown in gram negative organisms.